OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease.
Dmitry Victorovich Garbuzenko
PubMed (2022) Vol. 15, Iss. 3, pp. 194-203
Closed Access | Times Cited: 13

Showing 13 citing articles:

Systemic impacts of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) on heart, muscle, and kidney related diseases
Reddemma Sandireddy, Suganya Sakthivel, Priyanka Gupta, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 19

Metabolic Dysfunction-Associated Steatotic Liver Disease and the Cardiovascular System
Antonis A. Manolis, Theodora A. Manolis, Apostolos Vouliotis, et al.
Trends in Cardiovascular Medicine (2025)
Closed Access | Times Cited: 4

Cardiovascular morbidity and mortality in lean vs. non-lean MASLD: A comprehensive meta-analysis
Nso Nso, Damla Mergen, Mashaal Ikram, et al.
Current Problems in Cardiology (2024) Vol. 49, Iss. 6, pp. 102569-102569
Closed Access | Times Cited: 12

Non-alcoholic fatty liver disease (NAFLD) is associated with an increased incidence of chronic kidney disease (CKD)
Christoph Roderburg, Sarah Krieg, Andreas Krieg, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 21

Metabolic Dysfunction-Associated Steatotic Liver Disease: Pathogenetic Links to Cardiovascular Risk
Vlad Ionescu, Gina Gheorghe, Nicolae Bacalbaşa, et al.
Biomolecules (2025) Vol. 15, Iss. 2, pp. 163-163
Open Access

Cardiac Remodeling and Arrhythmic Burden in Pre-Transplant Cirrhotic Patients: Pathophysiological Mechanisms and Management Strategies
Charilila-Loukia Ververeli, Yannis Dimitroglou, Στέργιος Σουλαϊδόπουλος, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 812-812
Open Access

System failure: Systemic inflammation following spinal cord injury
Damon J. DiSabato, Christina M. Marion, Katherine A. Mifflin, et al.
European Journal of Immunology (2023) Vol. 54, Iss. 1
Open Access | Times Cited: 10

Non-Alcoholic Fatty Liver Disease and Coronary Artery Disease: A Bidirectional Association Based on Endothelial Dysfunction
Nikolaos Ktenopoulos, Μarios Sagris, Maria Gerogianni, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 19, pp. 10595-10595
Open Access | Times Cited: 3

Polyunsaturated and Saturated Oxylipin Plasma Levels Allow Monitoring the Non-Alcoholic Fatty Liver Disease Progression to Severe Stages
Miguel D. Ferrer, Clara Reynés, Margalida Monserrat-Mesquida, et al.
Antioxidants (2023) Vol. 12, Iss. 3, pp. 711-711
Open Access | Times Cited: 7

Insight to the association among fibroblast growth factor 21, non-alcoholic fatty liver disease and cardiovascular outcomes: A population-based study
Yun Shen, Tingting Hu, Hongyu Tan, et al.
Cytokine (2023) Vol. 170, pp. 156318-156318
Closed Access | Times Cited: 4

Liver Fibrosis as an Independent Cardiovascular Risk Factor in Non-alcoholic Fatty Liver Disease
Dmitry Victorovich Garbuzenko
Journal of Translational Gastroenterology (2024) Vol. 2, Iss. 1, pp. 21-29
Open Access

Page 1

Scroll to top